康泰生物(300601.SZ)发布上半年业绩，归母净利润3753.27万元，下降77.30%

Core Viewpoint - Kangtai Biological (300601.SZ) reported a significant decline in net profit for the first half of 2025, despite an increase in revenue, indicating potential challenges in profitability [1] Financial Performance - The company's operating revenue reached 1.392 billion yuan, representing a year-on-year growth of 15.81% [1] - The net profit attributable to shareholders was 37.53 million yuan, a decrease of 77.30% compared to the previous year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 18.46 million yuan, down 84.85% year-on-year [1] - Basic earnings per share were reported at 0.03 yuan [1]